株探米国株
英語
エドガーで原本を確認する
false2024Q30000066570--12-31P3Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puremsa:Segmentiso4217:GBPmsa:lawsuitmsa:claimmsa:classAction00000665702024-01-012024-09-3000000665702024-10-1800000665702024-07-012024-09-3000000665702023-07-012023-09-3000000665702023-01-012023-09-3000000665702024-09-3000000665702023-12-3100000665702023-01-012023-12-3100000665702022-12-3100000665702023-09-300000066570us-gaap:RetainedEarningsMember2023-06-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000066570us-gaap:RetainedEarningsMember2023-07-012023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000066570us-gaap:RetainedEarningsMember2023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000066570us-gaap:RetainedEarningsMember2024-06-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300000066570us-gaap:RetainedEarningsMember2024-07-012024-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300000066570us-gaap:RetainedEarningsMember2024-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300000066570us-gaap:RetainedEarningsMember2022-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000066570us-gaap:RetainedEarningsMember2023-01-012023-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300000066570us-gaap:RetainedEarningsMember2023-12-310000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000066570us-gaap:RetainedEarningsMember2024-01-012024-09-300000066570us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2024-01-012024-09-300000066570us-gaap:CorporateNonSegmentMember2024-01-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:CorporateNonSegmentMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2022-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2022-12-310000066570us-gaap:CorporateNonSegmentMember2022-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-01-012023-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2023-01-012023-12-310000066570us-gaap:CorporateNonSegmentMember2023-01-012023-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-12-310000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2023-12-310000066570us-gaap:CorporateNonSegmentMember2023-12-310000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2024-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalMember2024-09-300000066570us-gaap:CorporateNonSegmentMember2024-09-300000066570us-gaap:LandMember2024-09-300000066570us-gaap:LandMember2023-12-310000066570us-gaap:BuildingMember2024-09-300000066570us-gaap:BuildingMember2023-12-310000066570us-gaap:MachineryAndEquipmentMember2024-09-300000066570us-gaap:MachineryAndEquipmentMember2023-12-310000066570us-gaap:ConstructionInProgressMember2024-09-300000066570us-gaap:ConstructionInProgressMember2023-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-07-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2024-01-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-07-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300000066570us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-07-012024-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300000066570us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000066570us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300000066570us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300000066570us-gaap:CumulativePreferredStockMember2024-09-300000066570us-gaap:CumulativePreferredStockMember2024-01-012024-09-300000066570us-gaap:CumulativePreferredStockMember2023-12-310000066570us-gaap:PreferredStockMember2024-09-300000066570us-gaap:CumulativePreferredStockMember2023-01-012023-09-300000066570msa:SecondCumulativePreferredVotingStockMember2024-09-300000066570msa:SecondCumulativePreferredVotingStockMember2023-12-310000066570us-gaap:CommonStockMember2024-09-300000066570us-gaap:CommonStockMember2023-12-310000066570us-gaap:CommonStockMember2024-01-012024-09-300000066570us-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570us-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:CommonStockMember2024-06-300000066570us-gaap:TreasuryStockCommonMember2024-06-300000066570us-gaap:CommonStockMember2023-06-300000066570us-gaap:TreasuryStockCommonMember2023-06-300000066570us-gaap:CommonStockMember2024-07-012024-09-300000066570us-gaap:TreasuryStockCommonMember2024-07-012024-09-300000066570us-gaap:CommonStockMember2023-07-012023-09-300000066570us-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2024-07-012024-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2024-07-012024-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:CommonStockMember2024-07-012024-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2024-07-012024-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2024-07-012024-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2024-07-012024-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2024-07-012024-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2024-07-012024-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2023-07-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-07-012023-09-300000066570us-gaap:CommonStockMember2024-09-300000066570us-gaap:TreasuryStockCommonMember2024-09-300000066570us-gaap:CommonStockMember2023-09-300000066570us-gaap:TreasuryStockCommonMember2023-09-300000066570us-gaap:CommonStockMember2023-12-310000066570us-gaap:TreasuryStockCommonMember2023-12-310000066570us-gaap:CommonStockMember2022-12-310000066570us-gaap:TreasuryStockCommonMember2022-12-310000066570us-gaap:CommonStockMember2024-01-012024-09-300000066570us-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570us-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2024-01-012024-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570msa:RestrictedAndPerformanceStockAwardsMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:CommonStockMember2024-01-012024-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:EmployeeStockOptionMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2024-01-012024-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570us-gaap:StockCompensationPlanMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570msa:EmployeeStockPurchasePlanMemberus-gaap:CommonStockMember2024-01-012024-09-300000066570msa:EmployeeStockPurchasePlanMemberus-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570msa:EmployeeStockPurchasePlanMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570msa:EmployeeStockPurchasePlanMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2024-01-012024-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2024-01-012024-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:CommonStockMember2023-01-012023-09-300000066570msa:ShareRepurchaseProgramMemberus-gaap:TreasuryStockCommonMember2023-01-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2024-07-012024-09-300000066570us-gaap:CorporateNonSegmentMember2024-07-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2023-07-012023-09-300000066570us-gaap:CorporateNonSegmentMember2023-07-012023-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2024-01-012024-09-300000066570us-gaap:OperatingSegmentsMembermsa:InternationalSegmentMember2023-01-012023-09-300000066570msa:BreathingApparatusMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-07-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-07-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300000066570msa:AmericasSegmentMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-07-012024-09-300000066570msa:InternationalMember2024-07-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-07-012024-09-300000066570msa:BreathingApparatusMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300000066570msa:AmericasSegmentMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-07-012023-09-300000066570msa:InternationalMember2023-07-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-07-012023-09-300000066570msa:BreathingApparatusMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-01-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-01-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300000066570msa:AmericasSegmentMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2024-01-012024-09-300000066570msa:InternationalMember2024-01-012024-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2024-01-012024-09-300000066570msa:BreathingApparatusMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:BreathingApparatusMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570msa:BreathingApparatusMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:BreathingApparatusMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570msa:FixGasFlameDetectionInstrumentsMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FixGasFlameDetectionInstrumentsMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570msa:FirefighterHelmetsandProtectiveApparelMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMembermsa:FirefighterHelmetsandProtectiveApparelMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300000066570msa:AmericasSegmentMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:AmericasSegmentMember2023-01-012023-09-300000066570msa:InternationalMember2023-01-012023-09-300000066570us-gaap:ProductConcentrationRiskMemberus-gaap:SalesRevenueNetMembermsa:InternationalMember2023-01-012023-09-300000066570msa:DeferredTaxAssetMember2024-09-300000066570us-gaap:RestrictedStockMember2023-12-310000066570us-gaap:RestrictedStockMember2024-01-012024-09-300000066570us-gaap:RestrictedStockMember2024-09-300000066570srt:MinimumMember2024-01-012024-09-300000066570srt:MaximumMember2024-01-012024-09-300000066570us-gaap:PerformanceSharesMembermsa:MonteCarloApproachMember2024-01-012024-09-300000066570us-gaap:PerformanceSharesMember2024-01-012024-09-300000066570us-gaap:PerformanceSharesMember2023-12-310000066570us-gaap:PerformanceSharesMember2024-09-300000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2024-09-300000066570msa:SeniorNotesPayableThroughTwoThousandThirtyOneThreePointFourPercentageMemberMember2023-12-310000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2024-09-300000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMember2023-12-310000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2024-09-300000066570msa:NYLNoteFacilitySeriesASeniorNotesMember2023-12-310000066570msa:TermLoanFacility2023Memberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2024-09-300000066570msa:TermLoanFacility2023Memberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-12-310000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2024-09-300000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-12-3100000665702021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Memberus-gaap:BaseRateMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membermsa:OvernightBankFundingRateMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Memberus-gaap:SecuredOvernightFinancingRateSofrMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membersrt:MinimumMember2021-05-242021-05-240000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Membersrt:MaximumMember2021-05-242021-05-240000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:MultiCurrencyNoteSeriesCSeniorNotesMemberus-gaap:UnsecuredDebtMember2021-07-010000066570msa:MulticurrencyNotesDuein2031Memberus-gaap:NotesPayableOtherPayablesMember2024-09-300000066570msa:NYLNoteFacilitySeriesASeniorNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:NYLNoteFacilitySeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2021-07-010000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-06-290000066570msa:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2023-06-292023-06-290000066570msa:TermLoanFacility2023Memberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMember2023-01-050000066570msa:TermLoanFacility2023Memberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembersrt:MinimumMember2023-01-052023-01-050000066570msa:TermLoanFacility2023Memberus-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembersrt:MaximumMember2023-01-052023-01-0500000665702019-01-042019-01-040000066570us-gaap:StandbyLettersOfCreditMember2024-09-300000066570msa:SeniorRevolvingCreditFacilityMaturingIn2026Memberus-gaap:StandbyLettersOfCreditMember2024-09-300000066570msa:AmericasSegmentMember2024-09-300000066570msa:InternationalSegmentMember2024-09-300000066570msa:GlobeHoldingCompanyLLCMemberus-gaap:TradeNamesMember2024-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300000066570us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300000066570us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-300000066570us-gaap:ForeignExchangeForwardMember2024-09-300000066570us-gaap:ForeignExchangeForwardMember2023-12-310000066570us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2024-09-300000066570us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-12-310000066570us-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2024-09-300000066570us-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMember2023-12-310000066570us-gaap:NondesignatedMember2024-01-012024-09-300000066570us-gaap:NondesignatedMember2023-01-012023-09-300000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300000066570us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300000066570us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310000066570msa:SingleIncidentMember2024-09-300000066570msa:SingleIncidentMember2023-12-310000066570msa:SingleIncidentMember2024-01-012024-09-300000066570msa:SingleIncidentMember2023-01-012023-09-300000066570us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermsa:MSALLCMember2023-01-052023-01-050000066570msa:MSALLCMembermsa:JointVentureByRQInsuranceHoldingsLtdAndObraCapitalIncMember2023-01-052023-01-050000066570us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermsa:MSALLCMember2024-07-012024-09-300000066570us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermsa:MSALLCMember2024-01-012024-09-300000066570msa:DamagesFromProductSubstancesMemberus-gaap:SubsequentEventMember2024-10-1500000665702024-04-012024-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 10-Q
 
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2024
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File No. 1-15579
 image0a02a16.jpg
MSA SAFETY INCORPORATED
(Exact name of registrant as specified in its charter)
 
Pennsylvania   46-4914539
(State or other jurisdiction of
incorporation or organization)		   (IRS Employer
Identification No.)
1000 Cranberry Woods Drive
Cranberry Township, Pennsylvania   16066-5207
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: (724) 776-8600
Former name or former address, if changed since last report: N/A
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes  x   No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large Accelerated Filer x Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐   No  x
Securities registered pursuant to Section 12(b) of the Act: 
Title of each class Trading Symbol(s) Name of each exchange on which is registered
Common Stock, no par value MSA New York Stock Exchange
As of October 18, 2024, 39,309,950 shares of common stock, of the registrant were outstanding.

Table of Contents
Item No. Page
Part I
1.
2.
3.
4.
Part II
2.
6.

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
  Three Months Ended September 30, Nine Months Ended September 30,
(In thousands, except per share values) 2024 2023 2024 2023
Net sales $ 432,679  $ 446,728  $ 1,308,443  $ 1,292,290 
Cost of products sold 225,223  227,967  682,427  678,335 
Gross profit 207,456  218,761  626,016  613,955 
Selling, general and administrative 95,103  102,175  294,329  289,602 
Research and development 16,707  17,682  49,695  48,906 
Restructuring charges (Note 3) 1,184  3,285  5,744  8,382 
Currency exchange losses, net 2,985  1,496  4,715  8,781 
Loss on divestiture of MSA LLC (Note 17) —  —  —  129,211 
Product liability expense (Note 17) —  —  —  3 
Operating income 91,477  94,123  271,533  129,070 
Interest expense 9,153  12,498  29,556  37,149 
Other income, net (5,833) (6,037) (16,215) (15,487)
Total other expense, net 3,320  6,461  13,341  21,662 
Income before income taxes 88,157  87,662  258,192  107,408 
Provision for income taxes (Note 10) 21,509  22,406  61,171  125,235 
Net income (loss) $ 66,648  $ 65,256  $ 197,021  $ (17,827)
Earnings (loss) per share attributable to common shareholders (Note 9):
Basic $ 1.69  $ 1.66  $ 5.00  $ (0.46)
Diluted $ 1.69  $ 1.65  $ 4.98  $ (0.46)
Dividends per common share $ 0.51  $ 0.47  $ 1.49  $ 1.40 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
-3-
Table of Contents
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
Unaudited
  Three Months Ended September 30, Nine Months Ended September 30,
(In thousands) 2024 2023 2024 2023
Net income (loss) $ 66,648  $ 65,256  $ 197,021  $ (17,827)
Other comprehensive gain (loss), net of tax:
Foreign currency translation adjustments (Note 6) 21,329  (18,771) 1,834  (2,538)
Pension and post-retirement plan adjustments, net of tax (Note 6) 14  188  2,410  742 
Unrealized gain on available-for-sale securities (Note 6) —  —  —  2 
Reclassification of currency translation from accumulated other comprehensive loss into net income (Note 6) —  101  (1,200) 101 
Total other comprehensive gain (loss), net of tax 21,343  (18,482) 3,044  (1,693)
Comprehensive income (loss) $ 87,991  $ 46,774  $ 200,065  $ (19,520)

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
-4-
Table of Contents
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
Unaudited 
(In thousands) September 30, 2024 December 31, 2023
Assets
Cash and cash equivalents $ 154,371  $ 146,442 
Trade receivables, less allowance for credit loss of $7,937 and $7,065
 277,346  294,678 
Inventories (Note 4) 351,805  292,604 
Prepaid expenses and other current assets 59,147  52,546 
Total current assets
 842,669  786,270 
Property, plant and equipment, net (Note 5) 216,646  211,877 
Operating lease right-of-use assets, net 59,393  53,298 
Prepaid pension cost (Note 14) 183,915  172,161 
Deferred tax assets (Note 10) 34,513  33,065 
Goodwill (Note 13) 632,837  627,534 
Intangible assets, net (Note 13) 254,364  266,134 
Other noncurrent assets 17,590  19,811 
Total assets
 $ 2,241,927  $ 2,170,150 
Liabilities
Notes payable and current portion of long-term debt (Note 12) $ 26,915  $ 26,522 
Accounts payable 128,031  111,872 
Employees’ compensation 56,831  73,386 
Other current liabilities 102,701  121,038 
Total current liabilities
 314,478  332,818 
Long-term debt, net (Note 12) 527,807  575,170 
Pensions and other employee benefits (Note 14) 144,105  143,967 
Noncurrent operating lease liabilities 49,337  44,495 
Deferred tax liabilities (Note 10) 103,175  102,419 
Other noncurrent liabilities 7,680  4,479 
Total liabilities
 $ 1,146,582  $ 1,203,348 
Equity
Preferred stock, 4.5% cumulative, $50 par value (Note 7)
 $ 3,569  $ 3,569 
Common stock, no par value (Note 7)
 324,609  312,324 
Treasury shares, at cost (Note 7) (388,421) (363,284)
Accumulated other comprehensive loss (Note 6) (126,205) (129,249)
Retained earnings 1,281,793  1,143,442 
Total shareholders’ equity
 1,095,345  966,802 
Total liabilities and shareholders’ equity
 $ 2,241,927  $ 2,170,150 
    

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
-5-
Table of Contents
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Unaudited
  Nine Months Ended September 30,
(In thousands) 2024 2023
Operating Activities
Net income (loss) $ 197,021  $ (17,827)
Depreciation and amortization 47,563  44,965 
Tax-effected loss on divestiture of MSA LLC (Note 17) —  199,578 
Stock-based compensation (Note 11) 13,446  21,506 
Pension income (Note 14) (5,316) (6,060)
Deferred income tax benefit (Note 10) (1,928) (531)
Loss (gain) on asset dispositions, net 959  (671)
Pension contributions (Note 14) (3,948) (4,274)
Currency exchange losses, net 4,715  8,781 
Product liability expense (Note 17) —  3 
Product liability payments (Note 17) —  (5,250)
Contribution on divestiture of MSA LLC (Note 17) —  (341,186)
Changes in:
Trade receivables 7,965  (7,449)
Inventories (Note 4) (59,531) 15,386 
Accounts payable 17,309  (4,225)
Other current assets and liabilities (34,186) 26,518 
Other noncurrent assets and liabilities 4,451  4,679 
Cash Flow From (Used in) Operating Activities 188,520  (66,057)
Investing Activities
Capital expenditures (39,814) (30,979)
Property disposals and other investing 90  2,690 
Cash Flow Used in Investing Activities (39,724) (28,289)
Financing Activities
Proceeds from long-term debt (Note 12) 868,644  1,507,000 
Payments on long-term debt (Note 12) (919,647) (1,338,352)
Debt issuance costs (200) (1,138)
Cash dividends paid (58,670) (54,999)
Company stock purchases (Note 7) (27,427) (3,941)
Exercise of stock options (Note 7) 494  1,440 
Employee stock purchase plan (Note 7) 634  497 
Cash Flow (Used in) From Financing Activities (136,172) 110,507 
Effect of exchange rate changes on cash, cash equivalents and restricted cash (6,062) (14,152)
Change in cash, cash equivalents and restricted cash 6,562  2,009 
Beginning cash, cash equivalents and restricted cash 148,408  164,428 
Ending cash, cash equivalents and restricted cash $ 154,970  $ 166,437 
Supplemental cash flow information:
Cash and cash equivalents $ 154,371  $ 164,499 
Restricted cash included in prepaid expenses and other current assets 599  1,938 
Total cash, cash equivalents and restricted cash $ 154,970  $ 166,437 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
-6-
Table of Contents
MSA SAFETY INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN RETAINED EARNINGS
AND ACCUMULATED OTHER COMPREHENSIVE LOSS
Unaudited
(In thousands, except per share values) Retained
Earnings		 Accumulated
Other
Comprehensive
(Loss)
Balances June 30, 2023 $ 1,038,750  $ (141,928)
Net income 65,256  — 
Foreign currency translation adjustments —  (18,771)
Pension and post-retirement plan adjustments, net of tax expense of $27
 —  188 
Reclassification from accumulated other comprehensive loss into net income (Note 6) —  101 
Common dividends ($0.47 per share)
 (18,475) — 
Preferred dividends ($0.5625 per share)
 (10) — 
Balances September 30, 2023 $ 1,085,521  $ (160,410)
Balances June 30, 2024 $ 1,235,226  $ (147,548)
Net income 66,648  — 
Foreign currency translation adjustments —  21,329 
Pension and post-retirement plan adjustments, net of tax benefit of $374
 —  14 
Common dividends ($0.51 per share)
 (20,071) — 
Preferred dividends ($0.5625 per share)
 (10) — 
Balances September 30, 2024 $ 1,281,793  $ (126,205)
Balances December 31, 2022 $ 1,158,347  $ (158,717)
Net loss (17,827) — 
Foreign currency translation adjustments —  (2,538)
Pension and post-retirement plan adjustments, net of tax expense of $259
 —  742 
Unrecognized net gains on available-for-sale securities (Note 16) —  2 
Reclassification from accumulated other comprehensive loss into net income (Note 6) —  101 
Common dividends ($1.40 per share)
 (54,969) — 
Preferred dividends ($1.6875 per share)
 (30) — 
Balances September 30, 2023 $ 1,085,521  $ (160,410)
Balances December 31, 2023 $ 1,143,442  $ (129,249)
Net income 197,021  — 
Foreign currency translation adjustments —  1,834 
Pension and post-retirement plan adjustments, net of tax benefit of $628
 —  2,410 
Reclassification from accumulated other comprehensive loss into net income (Note 6) —  (1,200)
Common dividends ($1.49 per share)
 (58,640) — 
Preferred dividends ($1.6875 per share)
 (30) — 
Balances September 30, 2024 $ 1,281,793  $ (126,205)
The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.
-7-
Table of Contents
MSA SAFETY INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Unaudited
Note 1—Basis of Presentation
The condensed consolidated financial statements of MSA Safety Incorporated and its subsidiaries ("MSA" or "the Company") are unaudited. These unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, considered necessary by management to fairly state the Company's results. Intercompany accounts and transactions have been eliminated. The results reported in these unaudited condensed consolidated financial statements are not necessarily indicative of the results that may be expected for the entire year. The December 31, 2023, Balance Sheet data was derived from the audited Consolidated Balance Sheets, but does not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP"). This Form 10-Q report should be read in conjunction with MSA's Form 10-K for the year ended December 31, 2023, which includes all disclosures required by U.S. GAAP.
In November 2023, the FASB issued ASU No. 2023-07 (“ASU 2023-07”), Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 requires annual and interim disclosures that are expected to improve reportable segment disclosures, primarily through enhanced disclosures about significant expenses in determining segment profit or loss. The provisions of ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We will apply the new disclosure requirements of ASU 2023-07 in our 2024 Form 10-K and, with the exception of expanding disclosures about significant segment expenses, do not expect that the adoption of ASU 2023-07 will have a material effect on our consolidated financial statements taken as a whole.
Note 2—Cash and Cash Equivalents
Several of the Company's subsidiaries participate in a notional cash pooling arrangement to manage global liquidity requirements. As part of a master netting arrangement, the participants combine their cash balances in pooling accounts at the same financial institution with the ability to offset bank overdrafts of one participant against positive cash account balances held by another participant. Under the terms of the master netting arrangement, the financial institution has the right, ability and intent to offset a positive balance in one account against an overdrawn amount in another account. Amounts in each of the accounts are unencumbered and unrestricted with respect to use. As such, the net cash balance related to this pooling arrangement is included in Cash and cash equivalents in the unaudited Condensed Consolidated Balance Sheets.
The Company's net cash pool position consisted of the following:
(In thousands) September 30, 2024
Gross cash pool position $ 69,117 
Less: cash pool borrowings (65,712)
Net cash pool position $ 3,405 
Note 3—Restructuring Charges
During the three and nine months ended September 30, 2024, we recorded restructuring charges of $1.2 million and $5.7 million, respectively. Americas segment restructuring charges of $1.3 million during the nine months ended September 30, 2024, were related to manufacturing footprint optimization activities. International segment restructuring charges of $3.2 million during the nine months ended September 30, 2024, were related to ongoing initiatives to optimize our manufacturing footprint and improve productivity as well as management restructuring. Corporate segment restructuring charges of $1.2 million during the nine months ended September 30, 2024, were related to management restructuring.
During the three and nine months ended September 30, 2023, we recorded restructuring charges of $3.3 million and $8.4 million, respectively. Americas segment restructuring charges of $2.7 million during the nine months ended September 30, 2023, were related to manufacturing footprint optimization activities. International segment restructuring charges of $3.6 million during the nine months ended September 30, 2023, were related to ongoing initiatives to drive profitable growth and improve productivity. Corporate segment restructuring charges of $2.1 million during the nine months ended September 30, 2023, were related to footprint optimization activities and management restructuring.
-8-
Table of Contents
Restructuring reserves are included in Other current liabilities in the accompanying unaudited Condensed Consolidated Balance Sheets. Activity and reserve balances for restructuring by segment were as follows:
(In millions) Americas International Corporate Total
Reserve balances at December 31, 2022 $ 1.7  $ 12.8  $ 0.5  $ 15.0 
Restructuring charges 3.1  4.7  2.1  9.9 
Currency translation (0.1) 0.1  —  — 
Cash payments / utilization (3.9) (8.6) (2.6) (15.1)
Reserve balances at December 31, 2023 $ 0.8  $ 9.0  $ —  $ 9.8 
Restructuring charges 1.3  3.2  1.2  5.7 
Cash payments (1.9) (8.0) (1.2) (11.1)
Reserve balances at September 30, 2024 $ 0.2  $ 4.2  $ —  $ 4.4 
Note 4—Inventories
The following table sets forth the components of inventory:
(In thousands) September 30, 2024 December 31, 2023
Finished products $ 118,294  $ 88,687 
Work in process 17,369  15,378 
Raw materials and supplies 216,142  188,539 
Total inventories $ 351,805  $ 292,604 
Note 5—Property, Plant and Equipment
The following table sets forth the components of property, plant and equipment, net:
(In thousands) September 30, 2024 December 31, 2023
Land $ 4,379  $ 4,332 
Buildings 144,364  141,027 
Machinery and equipment 511,075  498,148 
Construction in progress 27,482  24,404 
Total 687,300  667,911 
Less: accumulated depreciation (470,654) (456,034)
Property, plant and equipment, net $ 216,646  $ 211,877 

-9-
Table of Contents
Note 6—Reclassifications Out of Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss were as follows:
Three Months Ended September 30, Nine Months Ended September 30,
(In thousands) 2024 2023 2024 2023
Pension and other post-retirement benefits (a)
Balance at beginning of period $ (40,256) $ (49,781) $ (42,652) $ (50,335)
Amounts reclassified from accumulated other comprehensive loss into net income (loss):
Amortization of prior service credit (Note 14) (9) (24) (27) (72)
Recognized net actuarial losses (Note 14) 397  185  3,065  555 
Tax (benefit) expense (374) 27  (628) 259 
Total amount reclassified from accumulated other comprehensive loss, net of tax, into net income (loss) 14  188  2,410  742 
Balance at end of period $ (40,242) $ (49,593) $ (40,242) $ (49,593)
Available-for-sale securities
Balance at beginning of period $ —  $ —  $ —  $ (2)
Unrealized net gains on available-for-sale securities (Note 16) —  —  —  2 
Balance at end of period $ —  $ —  $ —  $ — 
Foreign currency translation
Balance at beginning of period $ (107,292) $ (92,147) $ (86,597) $ (108,380)
Reclassification from accumulated other comprehensive loss into net income (loss)(b)
 —  101  (1,200) 101 
Foreign currency translation adjustments 21,329  (18,771) 1,834  (2,538)
Balance at end of period $ (85,963) $ (110,817) $ (85,963) $ (110,817)
(a) Amounts reclassified from accumulated other comprehensive loss into net income (loss) are included in the computation of net periodic pension and other post-retirement benefit costs (refer to Note 14—Pensions and Other Post-retirement Benefits).
(b) Reclassification from accumulated other comprehensive loss into net income (loss) relates primarily to the recognition of non-cash net cumulative translation gains associated with certain foreign subsidiaries. The reclassifications are included in Currency exchange losses, net, within the unaudited Condensed Consolidated Statements of Income.

-10-
Table of Contents
Note 7—Capital Stock
Preferred Stock - The Company has authorized 100,000 shares of $50 par value 4.5% cumulative preferred nonvoting stock which is callable at $52.50. There were 71,340 shares issued and 52,998 shares held in treasury at both September 30, 2024 and December 31, 2023. The Treasury shares at cost line in the unaudited Condensed Consolidated Balance Sheets includes $1.8 million related to preferred stock. There were no shares of preferred stock purchased and subsequently held in treasury during the nine months ended September 30, 2024 or 2023. The Company has also authorized 1,000,000 shares of $10 par value second cumulative preferred voting stock. No shares have been issued as of September 30, 2024, or December 31, 2023.
Common Stock - The Company has authorized 180,000,000 shares of no par value common stock. There were 62,081,391 shares issued as of September 30, 2024 and December 31, 2023. No new shares were issued during the nine months ended September 30, 2024 or 2023. There were 39,309,938 and 39,317,212 shares outstanding at September 30, 2024 and December 31, 2023, respectively.
Treasury Shares - The Company has a stock repurchase program that authorizes up to $200.0 million to repurchase MSA common stock in the open market and in private transactions. The stock repurchase program has no expiration date. The maximum number of shares that may be repurchased is calculated based on the dollars remaining under the program and the respective month-end closing share price. During the nine months ended September 30, 2024, and 2023, the Company repurchased 108,917 and no shares, respectively, under this and the prior stock repurchase program. There were 22,771,453 and 22,764,179 treasury shares at September 30, 2024 and December 31, 2023, respectively.
The Company issues treasury shares for all stock-based benefit plans. Shares are issued from treasury at the average treasury share cost on the date of the transaction. There were 141,618 and 125,967 Treasury shares issued for these purposes during the nine months ended September 30, 2024, and 2023, respectively.
Common stock activity is summarized as follows:
Three Months Ended September 30, 2024 Three Months Ended September 30, 2023
(In thousands) Common
Stock
Treasury
Cost(a)
 Common
Stock
Treasury
Cost(a)
Balance at beginning of period $ 320,556  $ (376,556) $ 294,364  $ (362,025)
Stock compensation expense 4,217  —  8,477  — 
Restricted and performance stock awards (275) 275  (15) 15 
Stock options exercised 111  57  591  307 
Treasury shares purchased for stock compensation programs —  (571) —  (70)
Share repurchase program —  (10,027) —  — 
Balance at end of period $ 324,609  $ (386,822) $ 303,417  $ (361,773)
(a)Excludes treasury cost related to preferred stock.
Nine Months Ended September 30, 2024 Nine Months Ended September 30, 2023
(In thousands) Common
Stock
Treasury
Cost(a)
 Common
Stock
Treasury
Cost(a)
Balance at beginning of period $ 312,324  $ (361,684) $ 281,980  $ (359,838)
Stock compensation expense 13,446  —  21,506  — 
Restricted and performance stock awards (2,058) 2,058  (1,449) 1,449 
Stock options exercised 323  171  948  492 
Treasury shares purchased for stock compensation programs —  (7,400) —  (3,941)
Employee stock purchase program 574  60  432  65 
Share repurchase program —  (20,027) —  — 
Balance at end of period $ 324,609  $ (386,822) $ 303,417  $ (361,773)
(a)Excludes treasury cost related to preferred stock.
-11-
Table of Contents
Note 8—Segment Information
The Company is organized into four geographical operating segments that are based on management responsibilities: Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The operating segments have been aggregated (based on economic similarities, the nature of their products, end-user markets and methods of distribution) into three reportable segments: Americas, International, and Corporate.
The Americas segment is comprised of our operations in Northern North American and Latin American geographies. The International segment is comprised of our operations in all geographies outside of the Americas. Certain global expenses are allocated to each segment in a manner consistent with where the benefits from the expenses are derived.
The Company's sales are allocated to each segment based primarily on the country destination of the end-customer.
Adjusted operating income (loss) is the measure used by the chief operating decision maker to evaluate segment performance and allocate resources. Adjusted operating income (loss) is defined as operating income (loss) excluding restructuring charges, currency exchange (gains) losses, product liability expense, loss on divestiture of Mine Safety Appliances Company, LLC ("MSA LLC"), net cost for product related legal matter, transaction costs and acquisition-related amortization.
The accounting principles applied at the operating segment level in determining the segment measure of profit or loss are the same as those applied at the unaudited condensed consolidated financial statement level. Sales and transfers between operating segments are accounted for at market-based transaction prices and are eliminated in consolidation.
Reportable segment information is presented in the following table:
(In thousands) Americas International Corporate Consolidated
Totals
Three Months Ended September 30, 2024
Net sales to external customers $ 299,497  $ 133,182  $ —  $ 432,679 
Adjusted operating income (loss) 91,822  18,174  (12,081) 97,915 
Three Months Ended September 30, 2023
Net sales to external customers $ 314,273  $ 132,455  $ —  $ 446,728 
Adjusted operating income (loss) 93,918  22,577  (15,198) 101,297 
(In thousands) Americas International Corporate Consolidated
Totals
Nine Months Ended September 30, 2024
Net sales to external customers $ 909,745  $ 398,698  $ —  $ 1,308,443 
Adjusted operating income (loss) 276,523  55,944  (38,353) 294,114 
Nine Months Ended September 30, 2023
Net sales to external customers $ 902,918  $ 389,372  $ —  $ 1,292,290 
Adjusted operating income (loss) 260,428  60,099  (38,066) 282,461 

-12-
Table of Contents
A reconciliation of total Adjusted operating income from reportable segments to Income before income taxes is presented in the following table:
Three Months Ended September 30, Nine Months Ended September 30,
(In thousands) 2024 2023 2024 2023
Adjusted operating income $ 97,915 $ 101,297 $ 294,114 $ 282,461
Less:
Restructuring charges (Note 3) 1,184 3,285 5,744 8,382
Currency exchange losses, net 2,985 1,496 4,715 8,781
Interest expense 9,153 12,498 29,556 37,149
Other income, net (5,833) (6,037) (16,215) (15,487)
Amortization of acquisition-related intangible assets 2,269 2,315 6,888 6,936
Transaction costs(a)
 — 78 234 78
Net cost for product related legal matter — — 5,000 —
Loss on divestiture of MSA LLC (Note 17) — — — 129,211
Product liability expense (Note 17) — — — 3
Income before income taxes 88,157 87,662 258,192 107,408
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during our evaluation of acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations.
-13-
Table of Contents
Total sales by product group was as follows:
Three Months Ended September 30, 2024 Consolidated Americas International
(In thousands, except percentages) Dollars Percent Dollars Percent Dollars Percent
Fire Service (a)
 $ 160,515  37% $ 111,992  37% $ 48,523  36%
Detection (b)
 163,150  38% 110,459  37% 52,691  40%
Industrial PPE and Other (c)
 109,014  25% 77,046  26% 31,968  24%
Total $ 432,679  100% $ 299,497  100% $ 133,182  100%
Three Months Ended September 30, 2023 Consolidated Americas International
(In thousands, except percentages) Dollars Percent Dollars Percent Dollars Percent
Fire Service (a)
 $ 175,732  39% $ 131,516  42% $ 44,216  33%
Detection (b)
 155,694  35% 105,007  33% 50,687  38%
Industrial PPE and Other (c)
 115,302  26% 77,750  25% 37,552  29%
Total $ 446,728  100% $ 314,273  100% $ 132,455  100%
Nine Months Ended September 30, 2024 Consolidated Americas International
(In thousands, except percentages) Dollars Percent Dollars Percent Dollars Percent
Fire Service (a)
 $ 496,478  38% $ 352,730  39% $ 143,748  36%
Detection (b)
 473,214  36% 318,159  35% 155,055  39%
Industrial PPE and Other (c)
 338,751  26% 238,856  26% 99,895  25%
Total $ 1,308,443  100% $ 909,745  100% $ 398,698  100%
Nine Months Ended September 30, 2023 Consolidated Americas International
(In thousands, except percentages) Dollars Percent Dollars Percent Dollars Percent
Fire Service (a)
 $ 481,610  37% $ 354,729  39% $ 126,881  33%
Detection (b)
 460,537  36% 308,692  34% 151,845  39%
Industrial PPE and Other (c)
 350,143  27% 239,497  27% 110,646  28%
Total $ 1,292,290  100% $ 902,918  100% $ 389,372  100%
(a) Fire Service includes Breathing Apparatus and Firefighter Helmets and Protective Apparel.
(b) Detection includes Fixed Gas and Flame Detection and Portable Gas detection.
(c) Industrial PPE and Other includes Industrial Head Protection, Fall Protection and Non-Core.

-14-
Table of Contents
Note 9—Earnings (Loss) per Share
Basic earnings (loss) per share is computed by dividing net income, after the deduction of preferred stock dividends and undistributed earnings allocated to participating securities, by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share assumes the issuance of common stock for all potentially dilutive share equivalents outstanding not classified as participating securities. Participating securities are defined as unvested stock-based compensation awards that contain nonforfeitable rights to dividends.
Three Months Ended September 30, Nine Months Ended September 30,
(In thousands, except per share values) 2024 2023 2024 2023
Net income (loss) $ 66,648  $ 65,256  $ 197,021  $ (17,827)
Preferred stock dividends (10) (10) (30) (30)
Net income (loss) attributable to common equity 66,638  65,246  196,991  (17,857)
Dividends and undistributed earnings allocated to participating securities (6) (8) (19) (16)
Net income (loss) attributable to common shareholders 66,632  65,238  196,972  (17,873)
Basic weighted-average shares outstanding 39,362  39,303  39,370  39,267 
Stock-based compensation awards(a)
 133  147  160  — 
Diluted weighted-average shares outstanding 39,495  39,450  39,530  39,267 
Antidilutive shares —  —  —  154 
Earnings (loss) per share:
Basic $ 1.69  $ 1.66  $ 5.00  $ (0.46)
Diluted $ 1.69  $ 1.65  $ 4.98  $ (0.46)
(a) During periods in which the Company incurs a net loss, stock-based compensation awards are excluded from the computation of diluted earnings per share because their effect would be anti-dilutive. As such, during periods in which the Company incurs a net loss, diluted weighted-average shares outstanding are equivalent to basic weighted-average shares outstanding.
Note 10—Income Taxes
The Company's effective tax rate for the three months ended September 30, 2024, was 24.4%, which differs from the United States of America ("U.S.") federal statutory rate of 21% primarily due to state income taxes. The Company's effective tax rate for the three months ended September 30, 2023, was 25.6%, which differs from the U.S. federal statutory rate of 21% primarily due to higher earnings in higher tax jurisdictions and nondeductible compensation.
The Company's effective tax rate for the nine months ended September 30, 2024, was 23.7%, which differs from the United States of America ("U.S.") federal statutory rate of 21% primarily due to state income taxes and nondeductible compensation. The Company's effective tax rate for the nine months ended September 30, 2023, was 116.6%, which differs from the U.S. federal statutory rate of 21% primarily due to the divestiture of MSA LLC and the non-deductible loss recorded on the derecognition of the product liability reserves and related assets. Refer to Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information on this transaction.
At September 30, 2024, the Company had a gross liability for unrecognized tax benefits of $7.2 million. The Company has recognized tax benefits associated with these liabilities of $0.6 million at September 30, 2024. The gross liability includes amounts associated with foreign tax exposure in prior periods.
The Company recognizes interest and penalties related to unrecognized tax benefits in interest expense and operating expenses, respectively. The Company's liability for accrued interest related to uncertain tax positions was $0.2 million at September 30, 2024.
We are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our tax positions will be sustained, the final outcome of tax audits and related litigation may differ materially from the tax amounts recorded in our unaudited condensed consolidated financial statements.
-15-
Table of Contents
Note 11—Stock Plans
The 2023 Management Equity Incentive Plan provides for various forms of stock-based compensation for eligible employees through May 2033 including stock options, restricted stock awards, restricted stock units and performance stock units. The 2024 Non-Employee Directors’ Equity Incentive Plan provides for grants of stock options, restricted stock awards and restricted stock units to non-employee directors through May 2034.
Stock compensation expense, included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations, is as follows:
  Three Months Ended September 30, Nine Months Ended September 30,
(In thousands) 2024 2023 2024 2023
Stock compensation expense $ 4,217  $ 8,477  $ 13,446  $ 21,506 
Income tax benefit 1,033  2,077  3,294  5,269 
Stock compensation expense, net of tax $ 3,184  $ 6,400  $ 10,152  $ 16,237 
We have not capitalized any stock-based compensation expense.
A summary of stock option activity for the nine months ended September 30, 2024, is as follows:
Shares Weighted Average
Exercise Price
Outstanding at January 1, 2024 26,536  $ 45.95 
Exercised (10,531) 46.95 
Forfeited (852) 48.65 
Outstanding and exercisable at September 30, 2024 15,153  $ 45.10 
Restricted stock awards and restricted stock units are valued at the market value of the stock on the grant date. A summary of restricted stock activity for the nine months ended September 30, 2024, is as follows:
Shares Weighted Average
Grant Date
Fair Value
Unvested at January 1, 2024 173,851  $ 142.73 
Granted 82,905  178.59 
Vested (48,596) 164.57 
Forfeited (25,482) 164.47 
Unvested at September 30, 2024 182,678  $ 150.16 
Performance stock units that have a market condition modifier are valued at an estimated fair value using a Monte Carlo model. The final number of shares to be issued for performance stock units granted in the first quarter of 2024 may range from 0% to 200% of the target award based on achieving the specified performance targets over the performance period plus an additional modifier based on total shareholder return ("TSR") over the performance period. The following weighted average assumptions were used in estimating the fair value of the performance stock units granted in the first quarter of 2024.
Fair value per unit $181.31
Risk-free interest rate 4.34%
Expected dividend yield 1.19%
Expected volatility 25.9%
MSA stock beta 0.728
The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date converted into an implied spot rate yield curve. Expected dividend yield is based on the most recent annualized dividend divided by the one year average closing share price. Expected volatility is based on the three year historical volatility preceding the grant date using daily stock prices. Expected life is based on historical stock option exercise data.
-16-
Table of Contents
A summary of performance stock unit activity for the nine months ended September 30, 2024, is as follows:
Shares Weighted Average
Grant Date
Fair Value
Unvested at January 1, 2024 189,221  $ 146.17 
Granted 40,787  177.34 
Performance adjustments(a)
 20,488  194.10 
Vested (77,544) 174.13 
Forfeited (10,619) 149.13 
Unvested at September 30, 2024 162,333  $ 146.50 
(a)Performance adjustments relate primarily to the final number of shares issued for the 2021 performance unit awards which vested in the first quarter of 2024 at 174% of the target award based on both cumulative performance against EBITDA margin and revenue growth targets and MSA's TSR during the three-year performance period.
Note 12—Long-Term Debt
(In thousands) September 30, 2024 December 31, 2023
2016 Senior Notes payable through 2031, 3.40%, net of debt issuance costs
 $ 57,067  $ 62,081 
2021 Senior Notes payable through 2036, 2.69%, net of debt issuance costs
 99,749  99,733 
2021 Senior Notes payable through 2036, 2.69%, net of debt issuance costs
 99,749  99,733 
2023 Term Loan credit agreement maturing in 2026, net of debt issuance costs 212,055  230,604 
2023 Senior Notes payable through 2028, 5.25%, net of debt issuance costs
 49,949  49,939 
Senior revolving credit facility maturing in 2026, net of debt issuance costs 36,153  59,602 
Total 554,722  601,692 
Amounts due within one year 26,915  26,522 
Long-term debt, net of debt issuance costs $ 527,807  $ 575,170 
On May 24, 2021, the Company entered into a Fourth Amended and Restated Credit Agreement (the “Revolving Credit Facility" or "Facility”) that extended its term through May 24, 2026 and increased the capacity to $900.0 million. The agreement was amended in August 2021 and June 2023 to transition from Sterling LIBOR reference rates and U.S. LIBOR reference rates. Under the amended agreement, the Company may elect either a Base rate of interest (“BASE”) or an interest rate based on Secured Overnight Financing Rate (“SOFR”). The BASE is a daily fluctuating per annum rate equal to the highest of (i) 0.00%, (ii) the Overnight Bank Funding Rate, plus 0.5%, (iii) the Prime Rate (iv) the Daily Simple SOFR rate, plus 1.00%. The Company pays a credit spread of 0 to 175 basis points based on the Company’s net EBITDA leverage ratio and elected rate (BASE or SOFR). The Company has a weighted average revolver interest rate of 5.80% as of September 30, 2024. At September 30, 2024, $861.5 million of the existing $900.0 million Revolving Credit Facility was unused, including letters of credit issued under the Facility. The Facility also provides an accordion feature that allows the Company to access an additional $400.0 million of capacity pending approval by MSA’s board of directors and from the bank group.
On July 1, 2024, the Company entered into Amendment No. 3 to the Third Amended and Restated Multi-Currency Note Purchase and Private Shelf Agreement (the “Prudential Note Agreement”) with PGIM, Inc. (“Prudential”). The Prudential Note Agreement provided for (i) the issuance of $100.0 million of 2.69% Series C Senior Notes due July 1, 2036 and (ii) the establishment of an uncommitted note issuance facility whereby the Company may request, subject to Prudential’s acceptance in its sole discretion, the issuance of up to $335.0 million aggregate principal amount of senior unsecured notes. As of September 30, 2024, the Company has outstanding £42.7 million (approximately $57.2 million at September 30, 2024) of 3.4% Series B Senior Notes due January 22, 2031. Remaining maturities of this note are £6.1 million (approximately $8.2 million at September 30, 2024) due annually through January 2031.
On July 1, 2024, the Company entered into Amendment No. 3 to the Second Amended and Restated Master Note Facility (the “NYL Note Facility”) with NYL Investors. The NYL Note Facility provided for (i) the issuance of $100.0 million of 2.69% Series A Senior Notes due July 1, 2036, and (ii) the establishment of an uncommitted note issuance facility whereby the Company may request, subject to NYL Investors’ acceptance in its sole discretion, the issuance of up to $200.0 million aggregate principal amount of senior unsecured notes.
-17-
Table of Contents
On June 29, 2023, the Company issued $50 million of 5.25% Series B Senior Notes due July 1, 2028, pursuant to the NYL Note Facility (the "Notes"). The Notes bear interest at 5.25% per annum, payable semi-annually, and mature on July 1, 2028. The Notes provide for a principal payment of $25 million on July 1, 2027, with the remaining $25 million due on July 1, 2028. The Notes may be redeemed at the Company’s option prior to their maturity at a make-whole redemption price calculated as provided in the NYL Note Facility. The proceeds of the Notes were used on June 29, 2023, to pay down an equivalent amount of borrowings under the Company’s Revolving Credit Facility with PNC Bank, National Association, as Administrative Agent.
On January 5, 2023, the Company entered into a new $250 million term loan facility to fund the divestiture of MSA LLC, a wholly owned subsidiary. Under the agreement, the Company may elect either BASE or an interest rate based on SOFR. The Company pays a credit spread of 0 to 200 basis points based on the Company's net EBITDA leverage ratio and elected rate. The Company had a Term Loan interest rate of 6.35% as of September 30, 2024.
The Revolving Credit Facility, Prudential Note Agreement and NYL Note Facility require the Company to comply with specified financial covenants, including a requirement to maintain a minimum fixed charges coverage ratio of not less than 1.50 to 1.00 and a consolidated leverage ratio not to exceed 3.50 to 1.00; except during an acquisition period, defined as four consecutive fiscal quarters beginning with the quarter of acquisition, in which case the consolidated net leverage ratio shall not exceed 4.00 to 1.00; in each case calculated on the basis of the trailing four fiscal quarters. In addition, the agreements contain negative covenants limiting the ability of the Company and its subsidiaries to incur additional indebtedness or issue guarantees, create or incur liens, make loans and investments, make acquisitions, transfer or sell assets, enter into transactions with affiliated parties, make changes in its organizational documents that are materially adverse to lenders or modify the nature of the Company's or its subsidiaries' business. All credit facilities exclude MSA LLC prior to the divestiture of this subsidiary on January 5, 2023, as discussed further in Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information on this transaction.
As of September 30, 2024, the Company was in full compliance with the restrictive covenants under its various credit agreements.
The Company had outstanding bank guarantees and standby letters of credit with banks as of September 30, 2024, totaling $10.0 million, of which $1.5 million relate to the Revolving Credit Facility. The letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. The Company is also required to provide cash collateral in connection with certain arrangements. At September 30, 2024, the Company has $0.6 million of restricted cash in support of these arrangements.
Note 13—Goodwill and Intangible Assets, Net
Changes in goodwill during the nine months ended September 30, 2024, were as follows:
(In thousands) Goodwill
Balance at January 1, 2024 $ 627,534 
Currency translation 5,303 
Balance at September 30, 2024 $ 632,837 
At September 30, 2024, goodwill of $447.6 million and $185.2 million related to the Americas and International reportable segments, respectively.
Changes in intangible assets, net, during the nine months ended September 30, 2024, were as follows:
(In thousands) Intangible Assets
Net balance at January 1, 2024 $ 266,134 
Amortization expense (13,392)
Currency translation 1,622 
Net balance at September 30, 2024 $ 254,364 
At September 30, 2024, intangible assets, net, includes a trade name related to Globe Manufacturing Company, LLC ("Globe") with an indefinite life totaling $60.0 million.
-18-
Table of Contents
Note 14—Pensions and Other Post-retirement Benefits
Components of Net periodic benefit (income) cost consisted of the following:
  Pension Benefits Other Benefits
(In thousands) 2024 2023 2024 2023
Three Months Ended September 30,
Service cost $ 2,315  $ 1,884  $ 44  $ 53 
Interest cost 5,970  5,918  248  273 
Expected return on plan assets (10,812) (9,906) —  — 
Amortization of prior service cost (credit) 37  37  (46) (61)
Recognized net actuarial losses 282  47  115  138 
Net periodic benefit (income) cost (a)
 $ (2,208) $ (2,020) $ 361  $ 403 
Nine Months Ended September 30,
Service cost $ 6,945  $ 5,652  $ 132  $ 159 
Interest cost 17,910  17,754  744  819 
Expected return on plan assets (32,436) (29,718) —  — 
Amortization of prior service cost (credit) 111  111  (138) (183)
Recognized net actuarial losses 846  141  345  414 
Settlements 1,308  — 

—  — 
Net periodic benefit (income) cost (a)
 $ (5,316) $ (6,060) $ 1,083  $ 1,209 
(a) Components of Net periodic benefit (income) cost other than service cost are included in the line item Other income, net, and service costs are included in the line items Cost of products sold and Selling, general and administrative in the unaudited Condensed Consolidated Statements of Operations.
We made contributions of $3.9 million and $4.3 million to our pension plans during the nine months ended September 30, 2024, and 2023, respectively. We expect to make net contributions of $5.3 million to our pension plans in 2024, which are primarily associated with statutorily required plans in the International reporting segment.
Note 15—Derivative Financial Instruments
As part of our currency exchange rate risk management strategy, we enter into certain derivative foreign currency forward contracts that do not meet the U.S. GAAP criteria for hedge accounting but have the impact of partially offsetting certain of our foreign currency exposures. We account for these forward contracts at fair value and report the related gains or losses in currency exchange losses, net, in the unaudited Condensed Consolidated Statements of Operations. The notional amount of open forward contracts was $184.8 million and $110.9 million at September 30, 2024, and December 31, 2023, respectively.
The following table presents the unaudited Condensed Consolidated Balance Sheets location and fair value of assets and liabilities associated with derivative financial instruments:
(In thousands) September 30, 2024 December 31, 2023
Derivatives not designated as hedging instruments:
Foreign exchange contracts: prepaid expenses and other current assets $ —  $ 2,210 
Foreign exchange contracts: other current liabilities 1,038  242 
-19-
Table of Contents
The following table presents the unaudited Condensed Consolidated Statements of Operations and unaudited Condensed Consolidated Statements of Cash Flows location and the loss impact of derivative financial instruments:
  Nine Months Ended September 30,
(In thousands) 2024 2023
Derivatives not designated as hedging instruments:
Foreign exchange contracts: currency exchange losses, net $ 1,683  $ 2,986 
Note 16—Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are:
•Level 1—Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities in active markets.
•Level 2—Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
•Level 3—Unobservable inputs for the asset or liability.
The valuation methodologies we used to measure financial assets and liabilities are also used to value the derivative financial instruments described in Note 15—Derivative Financial Instruments. We estimate the fair value of the derivative financial instruments, consisting of foreign currency forward contracts, based upon valuation models with inputs that generally can be verified by observable market conditions and do not involve significant management judgment. Accordingly, the fair values of the derivative financial instruments are classified within Level 2 of the fair value hierarchy. With the exception of our fixed rate long-term debt, we believe that the reported carrying amounts of our financial assets and liabilities approximate their fair values.
The reported carrying amount of our fixed rate long-term debt was $307.2 million and $312.2 million at September 30, 2024, and December 31, 2023, respectively. The fair value of this debt was $278.1 million and $278.7 million at September 30, 2024, and December 31, 2023, respectively. The fair value of this debt was determined using Level 2 inputs by evaluating similarly rated companies with publicly traded bonds where available or current borrowing rates available for financings with similar terms and maturities.
Note 17—Commitments and Contingencies
Product liability
The Company and its subsidiaries face an inherent business risk of exposure to legal claims arising from the alleged failure of our products to prevent the types of personal injury or death against which they are designed to protect. Product liability claims are categorized as either single incident or cumulative trauma.
Single incident product liability claims. Single incident product liability claims involve incidents of short duration that are typically known when they occur and involve observable injuries, which provide an objective basis for quantifying damages. Management has established reserves for the single incident product liability claims of the Company's various subsidiaries, including asserted single incident product liability claims and incurred but not reported ("IBNR") single incident claims. To determine the reserves, Management makes reasonable estimates of losses for single incident claims based on the number and characteristics of asserted claims, historical experience, sales volumes, expected settlement costs, and other relevant information. The reserve for single incident product liability claims was $0.8 million at September 30, 2024 and $1.3 million at December 31, 2023. Single incident product liability benefit was $0.2 million and $0.1 million for the nine months ended September 30, 2024, and 2023, respectively. Single incident product liability exposures are evaluated on an annual basis, or more frequently if changing circumstances warrant. Adjustments are made to the reserve as appropriate. The reserve has not been discounted to present value and does not include future amounts which will be spent to defend the claims.
During the first nine months of 2024, the Company recorded $5.0 million of net cost for product related legal matter. The expense is reflected within the selling, general and administration line of the unaudited Condensed Consolidated Statement of Operations.
-20-
Table of Contents
Cumulative trauma product liability claims. Cumulative trauma product liability claims involve alleged exposures to harmful substances (e.g., silica, asbestos and coal dust) that occurred years ago and may have developed over long periods of time into diseases such as silicosis, asbestosis, mesothelioma, or coal worker’s pneumoconiosis. Prior to the divestiture described below, one of the Company's former subsidiaries, MSA LLC, was named as a defendant in various lawsuits related to such claims. These lawsuits mainly involve respiratory protection products allegedly manufactured and sold by MSA LLC or its predecessors.
On January 5, 2023, the Company entered into a membership interest purchase agreement (the “Purchase Agreement”) with Sag Main Holdings, LLC (the “Buyer”). The Buyer was a joint venture between R&Q Insurance Holdings Ltd. (“R&Q”) and Obra Capital, Inc. (“Obra”). Under the Purchase Agreement, on January 5, 2023, the Company transferred to the Buyer all of the issued and outstanding limited liability company interests of MSA LLC (the “Sale”). In connection with the closing, the Company contributed $341.2 million in cash and cash equivalents, while R&Q and Obra contributed an additional $35.0 million.
MSA LLC was the obligor for the claims to which the Company's legacy cumulative trauma product liability reserves relate and policyholder of the related insurance assets. The rights and obligations related to these items remained with MSA LLC upon the sale to the Buyer. In addition, pursuant to the Purchase Agreement, the Buyer and MSA LLC have agreed to indemnify the Company and its affiliates for legacy cumulative trauma product liabilities and other product liabilities, and a subsidiary of the Company has agreed to indemnify MSA LLC for all other historical liabilities of MSA LLC. This indemnification is not subject to any cap or time limitation. In connection with the sale, the Company and its Board of Directors received a solvency opinion from an independent advisory firm that MSA LLC was solvent and adequately capitalized after giving effect to the transaction.
Following the completion of the transaction, the Company no longer has any obligation with respect to pending and future cumulative trauma product liability claims relating to these matters. As such, all legacy cumulative trauma product liability reserves, related insurance assets, and associated deferred tax assets of the divested subsidiary were derecognized from our balance sheet and the Company incurred a tax-effected loss on the divestiture of MSA LLC of $199.6 million, including transaction related costs of $5.6 million. The Buyer has assumed management of the divested subsidiary, including the management of its claims and associated assets.
Other Litigation
Globe, a subsidiary of the Company, is defending claims in which plaintiffs assert that certain products allegedly containing per- and polyfluoroalkyl substances (“PFAS”) have caused harm, including injury or health issues. PFAS are a large class of substances that are widely used in everyday products. Specifically, Globe builds firefighter turnout gear from technical fabrics sourced from a small pool of specialty textile manufacturers. These protective fabrics have been tested and certified to meet current National Fire Protection Association safety standards, and some of them as supplied to Globe contain or historically have contained PFAS to achieve performance characteristics such as water, oil, or chemical resistance.
Globe believes it has valid defenses to these claims. These matters are at a very early stage with numerous factual and legal issues to be resolved. Defense costs relating to these lawsuits are recognized in the unaudited Condensed Consolidated Statements of Operations as incurred. Globe is also pursuing insurance coverage and indemnification related to the lawsuits. As of October 15, 2024, Globe was named as a defendant in 535 lawsuits comprised of 7,850 claims, predominantly styled as individual personal injury claims and including two putative class actions. Certain of these lawsuits include MSA Safety Inc. or other Globe affiliates as defendants.
MSA LLC is also a defendant in a number of PFAS lawsuits predominantly relating to Aqueous Film-Forming Foam. The Buyer assumed responsibility for these and any similar future claims specific to MSA LLC, including such claims that have been or may be brought against MSA Safety Inc. or its subsidiaries, under the terms of the divestiture on January 5, 2023. Further information about the transaction can be found in the Company’s Current Report on Form 8-K filed on January 6, 2023.
-21-
Table of Contents
Product Warranty
The Company provides warranties on certain product sales. Product warranty reserves are established in the same period that revenue from the sale of the related products is recognized, or in the period that a specific issue arises as to the functionality of the Company's product. The determination of such reserves requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty.
The amounts of the reserves are based on established terms and the Company's best estimate of the amounts necessary to settle future and existing claims on products sold as of the balance sheet date. If actual return rates and/or repair and replacement costs differ significantly from estimates, adjustments to recognize additional cost of sales may be required in future periods.
The following table reconciles changes in the Company's accrued warranty reserve:
(In thousands) Nine Months Ended September 30, 2024 Year Ended
December 31, 2023
Beginning warranty reserve $ 14,288  $ 15,230 
Warranty payments (8,518) (9,794)
Warranty claims 7,370  8,899 
Provision for product warranties and other adjustments 515  (47)
Ending warranty reserve $ 13,655  $ 14,288 
Warranty expense was $7.9 million and $6.7 million for the nine months ended September 30, 2024, and 2023, respectively, and is included in Costs of products sold on the unaudited Condensed Consolidated Statements of Operations.
Outstanding Performance Obligations
The Company derives a portion of its revenue from various leasing arrangements where the Company is the lessor, primarily fire service contracts entered into by Bristol. Such arrangements provide for monthly payments covering equipment provided, maintenance and interest. These arrangements meet the criteria to be accounted for as sales-type leases under Accounting Standards Codification ("ASC") 842 and contain both lease and non-lease components.
Revenue from equipment provided is considered a lease component and recognized with point in time revenue recognition upon lease commencement. Maintenance revenue, which is considered a non-lease component, and interest is recognized monthly over the lease term. As of September 30, 2024, the Company had remaining maintenance performance obligations of approximately $28.7 million which are expected to be recognized to revenue in approximately three years.
-22-
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with the historical financial statements and other financial information included elsewhere in this quarterly report on Form 10-Q. This discussion may contain forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of our annual report entitled “Forward-Looking Statements” and “Risk Factors,” and those discussed in our Form 10-Q quarterly reports filed after such annual report (such as in Part II, Item 1A, “Risk Factors.”)

BUSINESS OVERVIEW
MSA Safety Incorporated is the global leader in advanced safety products, technology and solutions. Driven by its singular mission of safety, the Company has been at the forefront of safety innovation since 1914, protecting workers and facility infrastructure around the world across a broad range of diverse end markets while creating sustainable value for shareholders. The Company's comprehensive product line, which is governed by rigorous safety standards across highly regulated industries, is used to protect workers and facility infrastructures around the world in a broad range of markets, including fire service, energy, utility, construction and industrial manufacturing applications as well as heating, ventilation, air conditioning and refrigeration ("HVAC-R"). The Company's product portfolio includes fire service where core products include self-contained breathing apparatus ("SCBA"), protective apparel and helmets; detection where core products include fixed gas and flame detection ("FGFD") systems and portable gas detection instruments; and industrial personal protective equipment ("PPE") where core products include industrial head protection and fall protection devices.
A detailed listing of our significant product offerings in the aforementioned product groups above is included in MSA's Annual Report on Form 10-K for the year ended December 31, 2023.
We tailor our product offerings and distribution strategy to satisfy distinct customer preferences that vary across geographic regions. To best serve these customer preferences, we have organized our business into four geographical operating segments that are aggregated into three reportable segments: Americas, International and Corporate.
Americas. Our largest manufacturing and research and development facilities are located in the United States. We serve our markets across the Americas with manufacturing facilities in the U.S., Mexico and Brazil. Operations in the other countries within the Americas segment focus primarily on sales and distribution in their respective home country markets.
International. Our International segment includes companies in Europe, the Middle East and Africa ("EMEA") and the Asia Pacific region. In our largest International subsidiaries (Germany, France, U.K., Ireland and China), we develop, manufacture and sell a wide variety of products. In China, the products manufactured are sold primarily in China as well as in regional markets. Operations in other International segment countries focus primarily on sales and distribution in their respective home country markets. Although some of these companies may perform limited production, most of their sales are of products manufactured in our plants in Germany, France, the U.S., U.K., Ireland, Morocco and China or are purchased from third-party vendors.
Corporate. The Corporate segment primarily consists of general and administrative expenses incurred in our corporate headquarters, costs associated with corporate development initiatives, legal expense, interest expense, foreign exchange gains or losses and other centrally-managed costs. Corporate general and administrative costs comprise the majority of the expense in the Corporate segment.
-23-
Table of Contents
RESULTS OF OPERATIONS
Three Months Ended September 30, 2024, Compared to Three Months Ended September 30, 2023
Net Sales. Net sales for the three months ended September 30, 2024, were $432.7 million, a decrease of $14.0 million, or 3.1%, compared to $446.7 million in the same period last year. Please refer to the Net Sales table for a reconciliation of the quarter over quarter sales change.
Net Sales Three Months Ended September 30, Dollar
(Decrease)
Increase 		Percent
(Decrease)
Increase
(In millions, except percentage change) 2024 2023
Consolidated $432.7 $446.7 $(14.0) (3.1)%
Americas 299.5 314.3 (14.8) (4.7)%
International 133.2 132.4 0.8 0.6%
Net Sales Three Months Ended
September 30, 2024 versus September 30, 2023
(Percent Change) Americas International Consolidated
GAAP reported sales change (4.7)% 0.6% (3.1)%
Currency translation effects 1.3% (1.4)% 0.5%
Organic constant currency sales change (3.4)% (0.8)% (2.6)%
Note: Organic constant currency sales change is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section below.
Net sales for the Americas segment were $299.5 million in the third quarter of 2024, a decrease of $14.8 million, or 4.7%, compared to $314.3 million in the third quarter of 2023. Organic constant currency sales in the Americas segment decreased 3.4% during the period. This decrease was driven by a decline in fire service, primarily SCBA where delayed timing of large order delivery was a factor, partially offset by an increase in detection, primarily portables.
Net sales for the International segment were $133.2 million in the third quarter of 2024, an increase of $0.8 million, or 0.6%, compared to $132.4 million for the third quarter of 2023. Organic constant currency sales in the International segment decreased 0.8% during the period. Growth in fire service and detection was mostly offset by a decline in industrial PPE.
The operating environment remains dynamic. Looking forward, we expect to finish 2024 with mid-single-digit sales growth in the fourth quarter, resulting in low-single-digit top-line growth for the full year.
Refer to Note 8—Segment Information to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, for information regarding sales by product group.
Gross profit. Gross profit for the third quarter of 2024 was $207.5 million, a decrease of $11.3 million or 5.2%, compared to $218.8 million for the third quarter of 2023. The ratio of gross profit to net sales was 47.9% in the third quarter of 2024 compared to 49.0% in the same quarter last year. The decrease in gross profit margin is primarily related to lower sales volume. Effective price/cost management and productivity improvements offset inflationary pressures.
Selling, general and administrative expenses. Selling, general and administrative ("SG&A") expenses were $95.1 million during the third quarter of 2024, a decrease of $7.1 million or 6.9%, compared to $102.2 million for the same period a year ago. Overall, SG&A expenses were 22.0% of net sales during the third quarter of 2024, compared to 22.9% of net sales during the same period in 2023. Organic constant currency SG&A decreased by approximately $6.9 million or 6.7%. The decrease in SG&A was driven by lower variable compensation and discretionary expense management, partially offset by inflation and professional service expense related to strategic initiatives.
-24-
Table of Contents
Please refer to the SG&A expenses table for a reconciliation of the quarter over quarter expense change.
Selling, general, and administrative expenses Three Months Ended
September 30, 2024 versus September 30, 2023
(Percent Change) Consolidated
GAAP reported change (6.9)%
Currency translation effects 0.2%
Organic Constant currency change (6.7)%
Note: Organic constant currency SG&A change is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section below.
Research and development expense. Research and development expense was $16.7 million during the third quarter of 2024, a decrease of $1.0 million, compared to $17.7 million during the third quarter of 2023. Research and development expense was 3.9% of net sales in the third quarter of 2024 and 4.0% in the third quarter of 2023.
During the third quarter of 2024 and 2023, we capitalized $3.2 million and $3.3 million of software development costs, respectively. Depreciation expense for capitalized software development costs of $2.7 million for both the third quarter of 2024 and 2023, was recorded in costs of products sold on the unaudited Condensed Consolidated Statements of Operations.
MSA remains committed to dedicating significant resources to research and development activities, including the development of technology-based safety solutions. As we continue to invest a significant portion of our new product development into technology-based safety solutions, we anticipate that the historical relationship of research and development expense to net sales will continue to evolve; however, we do not anticipate reductions in the relative level of total spend on research and development activities on an annual basis. Total spend on both software development and research and development activities was $19.9 million and $21.0 million during the third quarter of September 30, 2024, and 2023, respectively.
Restructuring charges. Restructuring charges of $1.2 million during the third quarter of 2024 were primarily related to initiatives to optimize our manufacturing footprint and improve productivity. Restructuring charges of $3.3 million during the third quarter of 2023 were primarily related to initiatives to optimize our manufacturing footprint and drive profitable growth.
Currency exchange. Currency exchange losses were $3.0 million in the third quarter of 2024 compared to $1.5 million in the third quarter of 2023. The currency exchange activity for both periods related primarily to foreign currency exposure on unsettled inter-company balances and recognized exchange loss for our Argentina affiliate operating in a hyper-inflationary environment. Refer to Note 15—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.
GAAP operating income. Consolidated operating income for the third quarter of 2024 was $91.5 million compared to $94.1 million in the same period last year. The decrease in operating income was primarily driven by lower sales and gross profit partially offset by productivity improvements and lower SG&A as discussed further above.
Adjusted operating income. Americas adjusted operating income for the third quarter of 2024 was $91.8 million, a decrease of $2.1 million or 2.2% compared to $93.9 million in the prior year third quarter. The decrease in adjusted operating income is attributable to lower sales volumes partially offset by a decline in SG&A expenses. Effective price/cost management and productivity improvements offset inflationary pressures.
International adjusted operating income for the third quarter of 2024 was $18.2 million, a decrease of $4.4 million, or 19.5%, compared to $22.6 million in the prior year third quarter. The decrease in adjusted operating income is attributable to lower sales volumes partially offset by productivity improvements and pricing.
Corporate segment adjusted operating loss for the third quarter of 2024 was $12.1 million, a decrease of $3.1 million, compared to an adjusted operating loss of $15.2 million in the third quarter of 2023, driven by lower variable compensation partially offset by inflation and increased professional service fees associated with various strategic initiatives.
-25-
Table of Contents
The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss) and adjusted EBITDA. Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales and adjusted EBITDA margin % is calculated as adjusted EBITDA divided by net sales.
Adjusted operating income (loss) Three Months Ended September 30, 2024
(In thousands) Americas International Corporate Consolidated
Net sales to external customers $ 299,497  $ 133,182  $ —  $ 432,679 
Operating income 91,477 
Restructuring charges (Note 3) 1,184 
Currency exchange losses, net 2,985 
Amortization of acquisition-related intangible assets 2,269 
Adjusted operating income (loss) 91,822  18,174  (12,081) 97,915 
Adjusted operating margin % 30.7  % 13.6  %
Depreciation and amortization 13,690 
Adjusted EBITDA 101,339  22,119  (11,853) 111,605 
Adjusted EBITDA margin % 33.8  % 16.6  %
Adjusted operating income (loss) Three Months Ended September 30, 2023
(In thousands) Americas International Corporate Consolidated
Net sales to external customers $ 314,273  $ 132,455  $ —  $ 446,728 
Operating income 94,123 
Restructuring charges (Note 3) 3,285 
Currency exchange losses, net 1,496 
Amortization of acquisition-related intangible assets 2,315 
Transaction costs(a)
 78 
Adjusted operating income (loss) 93,918  22,577  (15,198) 101,297 
Adjusted operating margin % 29.9  % 17.0  %
Depreciation and amortization 13,189 
Adjusted EBITDA 103,157  26,289  (14,960) 114,486 
Adjusted EBITDA margin % 32.8  % 19.8  %
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during our evaluation of acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations.
Note: Adjusted operating income (loss), adjusted operating margin %, adjusted EBITDA and adjusted EBITDA margin % are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section below.
Total other expense, net. Total other expense, net, for the third quarter of 2024 was $3.3 million, compared to $6.5 million for the same period in 2023, driven primarily by decreased interest expense related to reduced debt balances related to prior year borrowings associated with the MSA LLC divestiture as well as increased pension income driven by a higher expected rate of return.

Income taxes. The reported effective tax rate for the third quarter of 2024 was 24.4% compared to 25.6% for the third quarter of 2023. The decrease from the prior year was primarily driven by discrete benefits booked in the third quarter of 2024 related to the filing of prior period tax returns and a decrease in nondeductible compensation.
We are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our tax positions will be sustained, the final outcome of tax audits and related litigation may differ materially from the tax amounts recorded in our unaudited condensed consolidated financial statements.
Net income. Net income was $66.6 million for the third quarter of 2024, or $1.69 per diluted share compared to $65.3 million, or $1.65 per diluted share, for the same period last year.
-26-
Table of Contents
Nine Months Ended September 30, 2024, Compared to Nine Months Ended September 30, 2023
Net Sales. Net sales for the nine months ended September 30, 2024, were $1.31 billion, an increase of $16.1 million, or 1.2%, compared to $1.29 billion in the same period last year. Please refer to the Net Sales table for a reconciliation of the period over period sales change.
Net Sales Nine Months Ended September 30, Dollar
Increase		 Percent
Increase
(In millions, except percentage change) 2024 2023
Consolidated $1,308.4 $1,292.3 $16.1 1.2%
Americas 909.7 902.9 6.8 0.8%
International 398.7 389.4 9.3 2.4%
Net Sales Nine Months Ended
September 30, 2024 versus September 30, 2023
(Percent Change) Americas International Consolidated
GAAP reported sales change 0.8% 2.4% 1.2%
Currency translation effects 0.3% (0.5)% 0.2%
Organic constant currency sales change 1.1% 1.9% 1.4%
Note: Organic constant currency sales change is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section below.
Net sales for the Americas segment were $909.7 million in the nine months ended September 30, 2024, an increase of $6.8 million, or 0.8%, compared to $902.9 million in the same period last year. Organic constant currency sales in the Americas segment increased 1.1% during the period. This growth was driven by an increase in detection.
Net sales for the International segment were $398.7 million in the nine months ended September 30, 2024, an increase of $9.3 million, or 2.4%, compared to $389.4 million in the same period last year. Organic constant currency sales in the International segment increased 1.9% during the period. This growth was driven by strength across fire service and detection, partially offset by a decline in industrial PPE.
Refer to Note 8—Segment Information to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, for information regarding sales by product group.
Gross profit. Gross profit for the nine months ended September 30, 2024, was $626.0 million, an increase of $12.0 million or 2.0%, compared to $614.0 million during the same period last year. The ratio of gross profit to net sales was 47.8% during the nine months ended September 30, 2024 compared to 47.5% during the same period last year. Volume leverage, price/cost management and productivity efforts offset inflationary pressures and contributed to the gross profit margin improvement.
Selling, general and administrative expenses. SG&A expenses were $294.3 million during the nine months ended September 30, 2024, an increase of $4.7 million or 1.6%, compared to $289.6 million during the same period last year. Overall, SG&A expenses were 22.5% of net sales during the nine months ended September 30, 2024, compared to 22.4% of net sales during the same period in 2023. Organic constant currency SG&A increased $5.1 million or 1.8%. The increase in SG&A was driven by higher commercial costs associated with volume growth, inflation, net cost for product related legal matter and higher professional service expense partially offset by lower variable compensation and discretionary cost management.
Please refer to the selling, general, and administrative expenses table for a reconciliation of the period over period expense change.
Selling, general, and administrative expenses Nine Months Ended
September 30, 2024 versus September 30, 2023
(Percent Change) Consolidated
GAAP reported change 1.6%
Currency translation effects 0.2%
Organic constant currency change 1.8%
Note: Organic constant currency SG&A change is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section below.

-27-
Table of Contents
Research and development expense. Research and development expense was $49.7 million during the nine months ended September 30, 2024, an increase of $0.8 million, compared to $48.9 million during the same period last year. Research and development expense was 3.8% of net sales in both the nine months ended September 30, 2024 and 2023.
During the nine months ended September 30, 2024 and 2023, we capitalized $10.0 million and $9.4 million of software development costs, respectively. Depreciation expense for capitalized software development costs of $8.2 million and $7.5 million during the nine months ended September 30, 2024 and 2023, respectively, was recorded in costs of products sold on the unaudited Condensed Consolidated Statements of Operations.
MSA remains committed to dedicating significant resources to research and development activities, including the development of technology-based safety solutions. As we continue to invest a significant portion of our new product development into technology-based safety solutions, we anticipate that the historical relationship of research and development expense to net sales will continue to evolve; however, we do not anticipate reductions in the relative level of total spend on research and development activities on an annual basis. Total spend on both software development and research and development activities was $59.7 million and $58.3 million during the nine months ended September 30, 2024, and 2023, respectively.
Restructuring charges. Restructuring charges of $5.7 million during the nine months ended September 30, 2024 were primarily related to ongoing initiatives to optimize our manufacturing footprint and improve productivity as well as management restructuring. Restructuring charges of $8.4 million during nine months ended September 30, 2023 related to our ongoing initiatives to adjust our cost structure and improve productivity. We remain focused on executing programs to optimize our cost structure.
Currency exchange. Currency exchange losses were $4.7 million during the nine months ended September 30, 2024, compared to $8.8 million in the same period of 2023. During 2024, we recognized non-cash net cumulative translation gains of $1.2 million associated with certain foreign subsidiaries. The remaining currency exchange activity for both periods related primarily due to foreign currency exposure on unsettled inter-company balances and recognized exchange loss for our Argentina affiliate operating in a hyper-inflationary environment.
Refer to Note 15—Derivative Financial Instruments to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q, for information regarding our currency exchange rate risk management strategy.
Product liability expense. Product liability expense for the nine months ended September 30, 2024, and 2023, was minimal due to our divestiture of MSA LLC in January 2023, as discussed further in Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q.
Loss on divestiture of MSA LLC. The $129.2 million pre-tax loss on divestiture of MSA LLC for the nine months ended September 30, 2023, relates to the derecognition of all legacy cumulative trauma product liability reserves and related insurance assets of the divested subsidiary during the first quarter of 2023. The loss also includes a $341.2 million contribution of cash and cash equivalents, as well as transaction related costs of $5.6 million. Refer to Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information.
GAAP operating income. Consolidated operating income for the nine months ended September 30, 2024, was $271.5 million compared to $129.1 million in the same period last year. The increase in operating results was driven by the higher sales and gross profit margin as well as the absence of loss on divestiture of MSA LLC that was recognized in 2023, partially offset by increased SG&A expense.
Adjusted operating income. Americas adjusted operating income for the nine months ended September 30, 2024 was $276.5 million, an increase of $16.1 million, or 6.2%, compared to $260.4 million in the prior year. The increase in adjusted operating income is primarily attributable to higher sales and gross profit margin due to effective price/cost management partially offset by higher SG&A expense to support business growth.
International adjusted operating income for the nine months ended September 30, 2024, was $55.9 million, a decrease of $4.2 million, or 6.9%, compared to $60.1 million in the prior year. The decrease in adjusted operating income is primarily attributable to lower sales volumes and unfavorable mix.
Corporate segment adjusted operating loss for the nine months ended September 30, 2024, was $38.4 million, an increase of $0.3 million compared to an adjusted operating loss of $38.1 million in the same period of 2023 driven by inflation and increased professional service fees associated with various strategic initiatives partially offset by lower variable compensation.
-28-
Table of Contents
The following tables represent a reconciliation from GAAP operating income to adjusted operating income (loss) and adjusted EBITDA. Adjusted operating margin % is calculated as adjusted operating income (loss) divided by net sales and adjusted EBITDA margin % is calculated as adjusted EBITDA divided by net sales.
Adjusted operating income (loss) Nine Months Ended September 30, 2024
(In thousands) Americas International Corporate Consolidated
Net sales to external customers $ 909,745  $ 398,698  $ —  $ 1,308,443 
GAAP operating income 271,533 
Restructuring charges (Note 3) 5,744 
Currency exchange losses, net 4,715 
Net cost for product related legal matter 5,000 
Amortization of acquisition-related intangible assets 6,888 
Transaction costs(a)
 234 
Adjusted operating income (loss) 276,523  55,944  (38,353) 294,114 
Adjusted operating margin % 30.4  % 14.0  %
Depreciation and amortization 40,675 
Adjusted EBITDA 305,275  67,216  (37,702) 334,789 
Adjusted EBITDA margin % 33.6  % 16.9  %
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during our evaluation of acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations.
Adjusted operating income (loss) Nine Months Ended September 30, 2023
(In thousands) Americas International Corporate Consolidated
Net sales to external customers $ 902,918  $ 389,372  $ —  $ 1,292,290 
GAAP operating income 129,070 
Restructuring charges (Note 3) 8,382 
Currency exchange losses, net 8,781 
Loss on divestiture of MSA LLC (Note 17) 129,211 
Product liability expense (Note 17) 3 
Amortization of acquisition-related intangible assets 6,936 
Transaction costs(a)
 78 
Adjusted operating income (loss) 260,428  60,099  (38,066) 282,461 
Adjusted operating margin % 28.8  % 15.4  %
Depreciation and amortization 38,029 
Adjusted EBITDA 287,628  70,296  (37,434) 320,490 
Adjusted EBITDA margin % 31.9  % 18.1  %
(a) Transaction costs include advisory, legal, accounting, valuation, and other professional or consulting fees incurred during our evaluation of acquisitions and divestitures. These costs are included in Selling, general and administrative expense in the unaudited Condensed Consolidated Statements of Operations.
Note: Adjusted operating income (loss), adjusted operating margin %, adjusted EBITDA and adjusted EBITDA margin % are non-GAAP financial measures. See the "Non-GAAP Financial Measures" section below.

-29-
Table of Contents
Total other expense, net. Total other expense, net, for the nine months ended September 30, 2024 was $13.3 million, compared to $21.7 million for the same period in 2023. The decrease in total other expense, net is primarily due to decreased interest expense related to reduced debt balances related to prior year borrowings associated with the MSA LLC divestiture as well as increased pension income driven by a higher expected rate of return partially offset by pension settlement expense recognized in the current year.
Income taxes. The reported effective tax rate for the nine months ended September 30, 2024 was 23.7% compared to 116.6% for the same period in 2023. This significant variance is primarily due to the divestiture of MSA LLC and the non-deductible loss recorded on the derecognition of the product liability reserves and related assets in the prior year. Refer to Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information on this transaction.
We are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our tax positions will be sustained, the final outcome of tax audits and related litigation may differ materially from the tax amounts recorded in our unaudited condensed consolidated financial statements.
Net income (loss) attributable to MSA Safety Incorporated. Net income was $197.0 million for the nine months ended September 30, 2024, or $4.98 per diluted share compared to net loss of $17.8 million, or $(0.46) per diluted share, for the same period last year.
Non-GAAP Financial Measures
This report includes certain non-GAAP financial measures and operating ratios derived from non-GAAP financial measures. These financial measures and ratios include organic constant currency revenue growth, organic constant currency SG&A change, adjusted operating income (loss), adjusted operating margin %, adjusted EBITDA and adjusted EBITDA margin %.
Organic constant currency sales and SG&A change are non-GAAP financial measures provided by the Company to give a better understanding of the Company's underlying business performance. Organic constant currency sales and SG&A change are calculated by deducting the percentage impact from currency translation effects from the overall percentage change in net sales and SG&A. The Company believes that organic constant currency revenue growth and SG&A change are useful metrics for investors, as foreign currency translation can have a material impact on revenue and SG&A trends. Organic constant currency revenue growth and SG&A change highlight ongoing business performance excluding the impact of fluctuating foreign currencies, which is outside of the Company's control.
Adjusted operating income (loss), adjusted operating margin %, adjusted EBITDA and adjusted EBITDA margin % are non-GAAP financial measures and operating ratios derived from non-GAAP measures. Adjusted operating income (loss) is reconciled above to the nearest GAAP financial measure, Operating income (loss), and excludes restructuring, currency exchange, product liability expense, loss on divestiture of MSA LLC, net cost for product related legal matter, transaction costs and acquisition-related amortization. Adjusted EBITDA is reconciled above to the nearest GAAP financial measure, Operating income (loss) and excludes depreciation and amortization expense. Adjusted operating margin % is defined as adjusted operating income (loss) divided by segment net sales to external customers and adjusted EBITDA margin % is defined as adjusted EBITDA divided by segment net sales to external customers. These metrics are consistent with how the Company's chief operating decision maker ("CODM") evaluates segment results and makes strategic decisions about the business. Additionally, these non-gaap financial measures provide information useful to investors in understanding our operating performance and trends, and to facilitate comparisons with the performance of our peers.
Management uses these measures internally to assess and better understand our underlying business performance and trends related to core business activities as well as to allocate resources. The non-GAAP financial measures and key performance indicators we use, and computational methods with respect thereto, may differ from the non-GAAP financial measures and key performance indicators, and computational methods, that our peers use to assess their performance and trends. The presentation of these non-GAAP financial measures does not comply with U.S. GAAP. These non-GAAP financial measures should be viewed as supplemental in nature, and not as a substitute for, or superior to, our reported results prepared in accordance with GAAP.
-30-
Table of Contents
LIQUIDITY AND CAPITAL RESOURCES
Our main source of liquidity is operating cash flows, supplemented by borrowings. Our principal liquidity requirements are for working capital, capital expenditures, principal and interest payments on debt, declared dividend payments and acquisitions. At September 30, 2024, approximately 55% of our long-term debt is at fixed interest rates with repayment schedules through 2036. The remainder of our long-term debt is at variable rates on an unsecured revolving credit facility and a term loan, both due in 2026. At September 30, 2024, approximately 90% of our borrowings are denominated in U.S. dollars, which limits our exposure to currency exchange rate fluctuations.
At September 30, 2024, the Company had cash and cash equivalents totaling $154.4 million and access to sufficient capital, providing ample liquidity and flexibility to continue to maintain our balanced capital allocation strategy that prioritizes growth investments, funding our dividends and servicing debt obligations. Cash, cash equivalents and restricted cash increased $6.6 million during the nine months ended September 30, 2024 compared to increasing $2.0 million during the same period in 2023. We believe MSA's healthy balance sheet and access to significant capital at September 30, 2024, positions us well to navigate through challenging business conditions, supply chain constraints and other unexpected events.
Operating activities. Operating activities provided cash of $188.5 million during the nine months ended September 30, 2024, compared to using cash of $66.1 million during the same period in 2023. The improved cash flow from operating activities as compared to the same period in 2023 was primarily related to the prior year contribution of $341.2 million in the divestiture of MSA LLC. Refer to Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further information. Excluding the cash flow impact of the MSA LLC divestiture for 2023, cash flow provided by operating activities decreased by $91.9 million, as improved operating results were completely offset by higher cash usage for working capital needs as well as increased cash usage for variable compensation payouts and tax prepayments both driven by prior year performance. The working capital cash usage increase related primarily to inventory purchases to support customer demand which were partially offset by improved accounts payable and accounts receivable management.
Investing activities. Investing activities used cash of $39.7 million during the nine months ended September 30, 2024, compared to using $28.3 million during the same period in 2023. The increase in cash used in investing activities as compared to the same period in 2023 was related to increased capital expenditures to support our manufacturing footprint optimization activities and IT systems implementation. We remain committed to evaluating additional acquisition opportunities that will allow us to continue to grow in key end markets and geographies.
Financing activities. Financing activities used cash of $136.2 million during the nine months ended September 30, 2024, compared to providing cash of $110.5 million during the same period in 2023. During the nine months ended September 30, 2024, we had net payments on long-term debt of $51.0 million as compared to net proceeds from long-term debt of $168.6 million during the same period in 2023 to fund the MSA LLC divestiture. We paid cash dividends of $58.7 million during the nine months ended September 30, 2024, compared to $55.0 million in the same period in 2023. We used cash of $27.4 million during the nine months ended September 30, 2024, to repurchase shares, including $20.0 million related to our share repurchase program and the remainder related to our employee stock compensation transactions compared to $3.9 million in the same period in 2023, all of which related to our employee stock compensation transactions.
-31-
Table of Contents
CUMULATIVE TRANSLATION ADJUSTMENTS
The position of the U.S. dollar relative to international currencies, primarily the euro, at September 30, 2024, resulted in a translation gain of $1.8 million being recorded to the cumulative translation adjustments shareholders' equity account during the nine months ended September 30, 2024, compared to a $2.5 million translation loss being recorded to the cumulative translation adjustments shareholders' equity account during the same period in 2023.
COMMITMENTS AND CONTINGENCIES
We made contributions of $3.9 million to our pension plans during the nine months ended September 30, 2024. We expect to make total contributions of approximately $5.3 million to our pension plans in 2024 primarily associated with statutorily required plans in the International segment.
The Company had outstanding bank guarantees and standby letters of credit with banks as of September 30, 2024, totaling $10 million, of which $1.5 million relate to the senior revolving credit facility. These letters of credit serve to cover customer requirements in connection with certain sales orders and insurance companies. The Company is also required to provide cash collateral in connection with certain arrangements. At September 30, 2024, the Company has $0.6 million of restricted cash in support of these arrangements.
We have purchase commitments for materials, supplies, services, and property, plant and equipment as part of our ordinary conduct of business.
Please refer to Note 17—Commitments and Contingencies to the unaudited condensed consolidated financial statements in Part I Item 1 of this Form 10-Q for further discussion on the Company's single incident and cumulative trauma product liabilities.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
We prepare our unaudited condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and the related disclosures. We evaluate these estimates and judgments on an on-going basis based on historical experience and various assumptions that we believe to be reasonable under the circumstances. However, different amounts could be reported if we had used different assumptions and in light of different facts and circumstances. Actual amounts could differ from the estimates and judgments reflected in our unaudited condensed consolidated financial statements.
The more critical judgments and estimates used in the preparation of our unaudited condensed consolidated financial statements are discussed in Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2023.
RECENTLY ADOPTED AND RECENTLY ISSUED ACCOUNTING STANDARDS
None.
-32-
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Market risk represents the risk of adverse changes in the value of a financial instrument caused by changes in currency exchange rates, interest rates and equity prices. We are exposed to market risks related to currency exchange rates and interest rates.
Currency exchange rate sensitivity. We are subject to the effects of fluctuations in currency exchange rates on various transactions and on the translation of the reported financial position and operating results of our non-U.S. companies from local currencies to U.S. dollars. A hypothetical 10% strengthening or weakening of the U.S. dollar would decrease or increase our reported sales and net income by approximately $17.5 million or 4.0% and $1.9 million or 2.8%, respectively, for the three months ended September 30, 2024.
When appropriate, we may attempt to limit our transactional exposure to changes in currency exchange rates through forward contracts or other actions intended to reduce existing exposures by creating offsetting currency exposures. At September 30, 2024, we had open foreign currency forward contracts with a U.S. dollar notional value of $184.8 million. A hypothetical 10% strengthening or weakening of the U.S. dollar would result in a $18.5 million increase or decrease in the fair value of these contracts at September 30, 2024.
Interest rates. We are exposed to changes in interest rates primarily as a result of borrowing and investing activities used to maintain liquidity and fund business operations.
At September 30, 2024, we had $307.2 million of fixed rate debt which matures at various dates through 2036. The incremental increase in the fair value of fixed rate long-term debt resulting from a hypothetical 10% decrease in interest rates would be approximately $7.6 million. However, our sensitivity to interest rate declines and the corresponding increase in the fair value of our debt portfolio would unfavorably affect earnings and cash flows only to the extent that we elected to repurchase or retire all or a portion of our fixed rate debt portfolio at prices above carrying values.
At September 30, 2024, we had $249.5 million of variable rate borrowings. A 100 basis point increase or decrease in interest rates would have a $2.6 million impact on future annual earnings under our current capital structure.
Item 4. Controls and Procedures
(a)Evaluation of disclosure controls and procedures. Based on their evaluation as of the end of the period covered by this Form 10-Q, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms and (ii) accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
(b)Changes in internal control. There were no changes in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
-33-
Table of Contents
PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c)Issuer Purchases of Equity Securities
Period Total Number of
Shares
Purchased		 Average Price Paid
Per Share		 Total Number of
Shares Purchased
As Part of Publicly
Announced Plans or
Programs		 Maximum Number
of Shares
That May Yet Be
Purchased Under
the Plans or
Programs
July 2024 4,717  $ 188.84  4,545  1,002,611 
August 2024 38,652  179.05  36,395  1,000,084 
September 2024 16,097  173.70  15,416  1,014,850 
The share repurchase program authorizes up to $200.0 million in repurchases of MSA common stock in the open market and in private transactions. The share repurchase program has no expiration date. The maximum number of shares that may be purchased is calculated based on the dollars remaining under the program and the respective month-end closing share price. There were 56,356 shares repurchased during the quarter ended September 30, 2024, under this program. We do not have any other share repurchase programs.
The shares purchased during the quarter, excluding those related to the share repurchase program, are related to stock-based compensation transactions.

Item 5. Other Information
During the three months ended September 30, 2024, no director or officer of the Company, nor the Company itself, adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
Item 6. Exhibits
(a) Exhibits
31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2        Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32        Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. (S)1350
101.INS        XBRL Instance Document
101.SCH    XBRL Taxonomy Extension Schema Document
101.CAL    XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF    XBRL Taxonomy Extension Definition Linkbase Document
101.LAB    XBRL Taxonomy Extension Label Linkbase Document
101.PRE        XBRL Taxonomy Extension Presentation Linkbase Document
104        Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)


-34-
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
    MSA SAFETY INCORPORATED
October 24, 2024   /s/ Lee B. McChesney
  Lee B. McChesney
  Senior Vice President and Chief Financial Officer
/s/ Jonathan D. Buck
Jonathan D. Buck
Chief Accounting Officer and Controller (Principal Accounting Officer)

-35-
EX-31.1 2 ex311-q32024.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a)
I, Steven C. Blanco, certify that:
1. I have reviewed this quarterly report on Form 10-Q of MSA Safety Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
October 24, 2024   /s/ Steven C. Blanco
  Steven C. Blanco
  President and Chief Executive Officer

EX-31.2 3 ex312-q32024.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a)
I, Lee B. McChesney certify that:
1. I have reviewed this quarterly report on Form 10-Q of MSA Safety Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
October 24, 2024   /s/ Lee B. McChesney
  Lee B. McChesney
  Senior Vice President and Chief Financial Officer

EX-32 4 ex32-q32024.htm EX-32 Document

EXHIBIT 32
CERTIFICATION
Pursuant to 18 U.S.C. (S) 1350, the undersigned officers of MSA Safety Incorporated (the “Company”), hereby certify, to the best of their knowledge, that the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, (the “Report”) fully complies with the requirements of Section 13 (a) or 15 (d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
October 24, 2024   /s/ Steven C. Blanco
  Steven C. Blanco
  President and Chief Executive Officer
  /s/ Lee B. McChesney
  Lee B. McChesney
  Senior Vice President and Chief Financial Officer